
==== Front
Ann Surg Oncol
Ann Surg Oncol
Annals of Surgical Oncology
1068-9265
1534-4681
Springer International Publishing Cham

38448738
15156
10.1245/s10434-024-15156-5
ASO Author Reflections
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma
Olthof Pim B. MD, PhD p.olthof@erasmusmc.nl

123
Groot Koerkamp Bas MD, PhD 1
the Perihilar Cholangiocarcinoma Collaboration GroupAldrighetti L.
Alikhanov R.
Bartsch F.
Bechstein W. O.
Bednarsch J.
Benzing C.
de Boer M. T.
Bouwense S. A.
Buettner S.
Capobianco I.
Cescon M.
Charco R.
D’Angelica M. I.
Dewulf M.
de Reuver P.
de Savornin Lohman E.
Efanov M.
Erdmann J. I.
Franken L. C.
Geers J.
Giglio M. C.
Gilg S.
Gomez-Gavara C.
Guglielmi A.
van Gulik T. M.
Hagendoorn J.
Hakeem A.
Heil J.
Hoogwater F. J. H.
IJzermans J. N. M.
Jansson H.
Jarnagin W. R.
Kazemier G.
Kingham T. P.
Lang H.
Lodge P.
Maithel S. K.
Malago M.
Malik H. Z.
Margies R.
Marino R.
Molenaar Q. I.
Nadalin S.
Neumann U.
Nguyen T. A.
Nooijen L. E.
Nota C. L. M.
Damink S. W. M. Olde
Poletto E.
Porte R. J.
Prasad R.
Pratschke J.
Quinn L. M.
Ratti F.
Ravaioli M.
Roberts K. J.
Rolinger J.
Ruzzenente A.
Schadde E.
Schmelzle M.
Schnitzbauer A. A.
Serenari M.
Sparrelid E.
Sultana A.
Topal B.
Troisi R. I.
van Laarhoven S.
Zonderhuis B. M.

1 https://ror.org/018906e22 grid.5645.2 0000 0004 0459 992X Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
2 https://ror.org/05grdyy37 grid.509540.d 0000 0004 6880 3010 Department of Surgery, Amsterdam UMC, Amsterdam, The Netherlands
3 grid.4494.d 0000 0000 9558 4598 Department of Surgery, University Medical Center, Groningen, Groningen, The Netherlands
6 3 2024
6 3 2024
2024
31 7 44544455
20 2 2024
20 2 2024
© The Author(s) 2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
issue-copyright-statement© Society of Surgical Oncology 2024
==== Body
pmcPast

The goal in the surgical treatment of perihilar cholangiocarcinoma is complete R0 resection, which usually requires major liver resection. The extent of biliary or vascular involvement can dictate the side of the liver that has to be resected. In other cases, a left- or right-sided liver resection can be chosen, which is a frequent subject of debate. Often, an extended right hepatectomy is advocated for the highest probability of R0 resection, however this is associated with a high risk of liver failure due to the small liver remnant.1,2

Present

We performed a large retrospective study on 816 patients who underwent left-sided liver resection and 855 patients who underwent right-sided liver resection for perihilar cholangiocarcinoma.3 The 90-day mortality rate after right-sided resection was twice that after left-sided resection (18% vs. 9%; p < 0.001). Positive resection margins were similar for both groups but median overall survival was 23 months after right-sided liver resection and 30 months after left-sided liver resection (p < 0.001).

Future

This study is the largest to date on this subject and highlights that a left-sided resection strategy is better tolerated and is associated with better survival. This study contradicts that extended right hepatectomy should be preferentially performed for perihilar cholangiocarcinoma. It also highlights that the perioperative risks of perihilar cholangiocarcinoma surgery are among the highest of any elective cancer surgery. Modifiable risk factors to decrease liver failure after extended right hepatectomy include better preoperative biliary drainage with less preoperative cholangitis, and liberal use of portal/hepatic vein embolization.4,5 A prospective study including all surgical decision-making details might be essential to finally settle the debate on the optimal surgical approach.

Acknowledgment

Perihilar Cholangiocarcinoma Collaboration Group: Aldrighetti L, Alikhanov R, Bartsch F, Bechstein WO, Bednarsch J, Benzing C, de Boer MT, Bouwense SA, Buettner S, Capobianco I, Cescon M, Charco R, D'Angelica MI, Dewulf M, de Reuver P, de Savornin Lohman E, Efanov M, Erdmann JI, Franken LC, Geers J, Giglio MC, Gilg S, Gomez-Gavara C, Guglielmi A, van Gulik TM, Hagendoorn J, Hakeem A, Heil J, Hoogwater FJH, IJzermans JNM, Jansson H, Jarnagin WR, Kazemier G, Kingham TP, Lang H, Lodge P, Maithel SK, Malago M, Malik HZ, Margies R, Marino R, Molenaar QI, Nadalin S, Neumann U, Nguyen TA, Nooijen LE, Nota C.L.M, Olde Damink SWM, Poletto E,Porte RJ, Prasad R, Pratschke J, Quinn LM, Ratti F, Ravaioli M, Roberts KJ, Rolinger J, Ruzzenente A, Schadde E, Schmelzle M, Schnitzbauer AA, Serenari M, Sparrelid E, Sultana A, Topal B, Troisi RI, van Laarhoven S, Zonderhuis BM.

Disclosure

Pim B. Olthof and Bas Groot Koerkamp report no relevant conflicts of interest or relevant funding.

This article refers to: Olthof PB, Erdmann JI, Alikhanov R, et al. Higher postoperative mortality and inferior survival after right-sided liver resection for perihilar cholangiocarcinoma: left-sided resection is preferred when possible. Ann Surg Oncol. 2024. 10.1245/s10434-024-15115-0

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Lang H van Gulik TM Extended right-hemihepatectomy is preferred for perihilar cholangiocarcinoma Ann Surg. 2021 274 1 33 34 10.1097/SLA.0000000000004821 33605597
2. Matsumoto N Ebata T Yokoyama Y Igami T Sugawara G Shimoyama Y Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma Br J Surg. 2014 101 3 261 268 10.1002/bjs.9383 24399779
3. Olthof PB, Erdmann JI, Alikhanov R, et al. Higher postoperative mortality and inferior survival after right-sided liver resection for perihilar cholangiocarcinoma: left-sided resection is preferred when possible. Ann Surg Oncol. 2024. 10.1245/s10434-024-15115-0
4. Olthof PB Wiggers JK Groot Koerkamp B Coelen RJ Allen PJ Besselink MG Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization J Am Coll Surg. 2017 225 3 387 394 10.1016/j.jamcollsurg.2017.06.007 28687509
5. Wiggers JK, Groot Koerkamp B, Cieslak KP, Doussot A, van Klaveren D, Allen PJ, et al. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg. 2016;223(2):321-31 e1.
